• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 8, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume8, Issue3

Predictive Value Of 14-3-3 Eta Protein as A Novel Biomarker in Juvenile Idiopathic Arthritis (Oligoarticular Type): Relation to Activity and Severity of The Disease

    Amany Abo Elsoud, Nahla I. Elattar, Dina A. Abd Elhafeezc, Ibrahim T. Abdelal

European Journal of Molecular & Clinical Medicine, 2021, Volume 8, Issue 3, Pages 4543-4551

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Juvenile idiopathic arthritis (JIA) is a term that encompasses all forms of
arthritis that begin before a patient is aged 16 years that persist for more than 6 weeks and
are of unknown origin. It is the most common childhood chronic rheumatic disease and
causes much disability. We investigated the relation of serum 14-3-3 η (eta) protein in
oligoarticular JIA (OJIA) and; the disease activity and severity.
Methods: This study is a case control study including 14 JIA patients and 14 control
group. Patients were (6 males and 8 females).14-3-3η was measured for all patients and
control volunteers by enzyme-linked immunosorbent assay (ELISA) technique. ANA was
measured by indirect immunofluorescence (IIF) technique. Disease activity was assessed
by the Juvenile Arthritis Disease Activity Score27 (JADAS-27). Functional ability was
assessed by childhood health assessment questionnaire (CHAQ), and disease severity was
assessed by juvenile arthritis damage index (JADI). Radiological damage was assessed by
Poznanski score.
Results: Elevated 14-3-3 η levels were detected in 5/14 (35.7%) patients. Positivity for 14-
3-3 η was significantly related to disease activity, severity and ANA. Positivity for 14-3-3 η
had no significant correlation with CHAQ or Posnanski score.
Conclusion: Serum 14-3-3 η can be detected in oligoarticular JIA patients, and appears to
correlate with disease activity, severity and (ANA). But no correlation with CHAQ or
Poznanski score.
Keywords:
    Juvenile idiopathic arthritis oligoarticular JIA biomarker 14-3-3(eta) activity Severity
  • PDF (616 K)
  • XML
(2021). Predictive Value Of 14-3-3 Eta Protein as A Novel Biomarker in Juvenile Idiopathic Arthritis (Oligoarticular Type): Relation to Activity and Severity of The Disease. European Journal of Molecular & Clinical Medicine, 8(3), 4543-4551.
Amany Abo Elsoud, Nahla I. Elattar, Dina A. Abd Elhafeezc, Ibrahim T. Abdelal. "Predictive Value Of 14-3-3 Eta Protein as A Novel Biomarker in Juvenile Idiopathic Arthritis (Oligoarticular Type): Relation to Activity and Severity of The Disease". European Journal of Molecular & Clinical Medicine, 8, 3, 2021, 4543-4551.
(2021). 'Predictive Value Of 14-3-3 Eta Protein as A Novel Biomarker in Juvenile Idiopathic Arthritis (Oligoarticular Type): Relation to Activity and Severity of The Disease', European Journal of Molecular & Clinical Medicine, 8(3), pp. 4543-4551.
Predictive Value Of 14-3-3 Eta Protein as A Novel Biomarker in Juvenile Idiopathic Arthritis (Oligoarticular Type): Relation to Activity and Severity of The Disease. European Journal of Molecular & Clinical Medicine, 2021; 8(3): 4543-4551.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 165
  • PDF Download: 223
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus